Table 1.

Effect of cycloheximide treatment on the abundance of KSHV lytic-cycle mRNAs

Cycloheximide dosea(μg/ml)% of KSHV gene:
RtaK8vIL-6PAN
  0100100100100
 1028443
 3323332
10024643
  • a Cycloheximide included from 0 to 13 h during n-butyrate treatment.